Lysogene has appointed two executives to its financial team. Berndt A. Modig joins the firm as its Senior Financial Advisor. In his role with the company, Mr. Modig will be the most senior Finance staff member.

Mr. Modig has spent more than 30 years in finance, with a large portion of that time being spent in healthcare finance. His most recent roles include Chief Financial Officer at Prosensa, which was acquired by BioMarin, and Chief Financial Officer at Jerini AG, which was acquired by Shire. His extensive international background also includes experience with the successful execution of complex financial strategies, operations management and audit committee roles.

Mr. Modig is currently serving on the boards of Axovant Sciences Ltd., Auris Medical AG and Affimed N.V., and he will maintain those positions as he assumes his new role at Lysogene. Sarah Ankri joins the team as Finance Director. Prior to joining Lysogene, Ms. Ankri was CFO at Theraclion and successfully led the company's IPO in 2014.